Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
J Ayub Med Coll Abbottabad ; 35(1): 54-59, 2023.
Article in English | MEDLINE | ID: mdl-36849377

ABSTRACT

BACKGROUND: The irrational use of antibiotics has led to the emergence of multi drug resistant pathogens. The phenomenon of MIC creeps occurs when organisms start showing raised MIC but within susceptible range giving an indication of the prevalence of rise in resistant pathogens in an area. METHODS: A cross sectional study in a large tertiary care hospital in North India to observe the susceptibility pattern among uropathogens and the possibility of MIC creeps. The Antimicrobial Susceptibility Testing (AST) and Minimum Inhibitory Concentration (MIC) were conducted by Vitek Compact 2. The identification of Extended Spectrum Beta Lactamase (ESBL) producers and Carbapenem Resistant Enterobacteriaceae (CRE) among Escherichia coli were noted. The MIC 50 and MIC 90 for Nitrofurantoin, the most widely used antibiotic for lower UTI, was calculated to investigate the phenomenon of MIC creep. RESULTS: In our study, a total of 2522 urine samples were analyzed: 1538 (61%) were positive with the commonest isolate being E. coli (n=736, 47.8%) followed by Klebsiella spp. (n=178, 11%). Less than 10% of resistance was observed for Fosfomycin, Amikacin, Nitrofurantoin, Imipenem, Meropenem and Colistin. ESBL producers and CRE E. coli were 528 (72% of 736) and 79 (11% of 736) respectively. Overall, 119/736 samples had an MIC ≥128. Amongst the ESBL producers, 96/528 had MIC ≥128 and amongst the CRE, 13/79 had MIC ≥128. DISCUSSION: E. coli can be used to reflect the trends in development of resistance. In the current study, it was observed that E. coli showed a reduced susceptibility for Nitrofurantoin indicated by a creeping increase in MIC albeit within normal range. CONCLUSIONS: Trends in rising MIC should alert prescribers to use drugs such as Nitrofurantoin judiciously. Antimicrobial stewardship practices should be strongly implemented in hospitals to curb rising resistance and obtain better treatment outcomes for patients with infectious diseases.


Subject(s)
Escherichia coli , Nitrofurantoin , Humans , Nitrofurantoin/pharmacology , Nitrofurantoin/therapeutic use , Cross-Sectional Studies , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Microbial Sensitivity Tests
2.
Article in English | MEDLINE | ID: mdl-19323045

ABSTRACT

The study was conducted to evaluate a new cefixime-clavulanic acid combination for in vitro susceptibility towards gram-negative bacteria. A total of 220 isolates of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeroginosa, Acinetobacter spp, Salmonella enterica serovar Typhi and Salmonella enterica serovar Typhimurium were included in the study. The isolates were tested for susceptibility towards the new combination antimicrobial molecule cefixime with clavulanic acid by disk diffusion and Epsilometer strip (E-strip) Minimum Inhibitary Concentration (MIC) method. Of the 101 E. coli and K. pneumoniae isolates, 62.4% were found to be extended spectrum beta-lactamase (ESBL) producers. Almost half of these were from the community and 55.6% were hospital isolates. Of the ESBL isolates, 19% were AmpC (cephalosporinases that are poorly inhibited by beta lactamase inhibitor) producers while the remaining 81% were non AmpC ESBL producers. The AmpC producers were resistant to both cefixime and the combination, while the non-AmpC producers were sensitive to the combination. The addition of clavulanate to cefixime did not improve the sensitivities of P. aeruginosa and Acinetobacter isolates. There were no ESBL isolates among the S. Typhi isolates, all of which were sensitive to cefixime. Of the S. Typhimurium, 88.9% were ESBL producers and all of these were resistant to cefixime but sensitive to the combination. The combination of cefixime with clavulanic acid offers the advantage of oral administration and appears to be a viable option for the treatment of uncomplicated community acquired infections caused by non-AmpC ESBL producing gram-negative bacteria.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cefixime/therapeutic use , Clavulanic Acid/therapeutic use , Gram-Negative Bacteria/drug effects , Gram-Negative Bacterial Infections/drug therapy , beta-Lactamases/biosynthesis , Anti-Bacterial Agents/therapeutic use , Cefixime/pharmacology , Clavulanic Acid/pharmacology , Community-Acquired Infections/drug therapy , Community-Acquired Infections/microbiology , Cross Infection/drug therapy , Cross Infection/microbiology , Disk Diffusion Antimicrobial Tests , Drug Resistance, Multiple, Bacterial , Drug Therapy, Combination , Enzyme Inhibitors/pharmacology , Enzyme Inhibitors/therapeutic use , Gram-Negative Bacteria/enzymology , Gram-Negative Bacteria/isolation & purification , Humans , Microbial Sensitivity Tests
3.
Arch Orthop Trauma Surg ; 128(1): 121-4, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17503061

ABSTRACT

BACKGROUND: Isolated actinomycosis of the humerus is a very rare entity. METHOD: A 30-year-old male had an erythematous plaque with a pus-(minimal) discharging sinus over left lower arm. The patient had no discharge of sulphur granules from the sinus. The patient had raised ESR with a single lytic lesion with minimal sclerosis and inconspicuous periosteal reaction on radiographs. Such atypical clinical and radiological features lead to initial wrong diagnosis of tuberculosis. A diagnosis of Actinomycosis of humerus became possible after demonstration of filamentous bacilli in culture and on histopathology from the sulphur grains obtained by open biopsy. RESULT: The patient recovered completely after administering PenicillinG 24 million units intravenous for 7 days followed by 1.2 g of oral amoxicillin in three divided doses for 3 months and did not show any recurrence during last 2 years of follow up. CONCLUSION: Surgeons should be aware of this rare entity and difficulty in its diagnosis due to its variable manifestations, including confusion with highly endemic tuberculous infection. Awareness of full spectrum of the diseases and careful evaluation in individual cases will expedite diagnosis and avoid unnecessary surgical interventions.


Subject(s)
Actinomycosis/diagnosis , Bone Diseases, Infectious/diagnosis , Humerus/microbiology , Actinomycosis/drug therapy , Adult , Amoxicillin/administration & dosage , Anti-Bacterial Agents/administration & dosage , Bone Diseases, Infectious/drug therapy , Humans , Humerus/diagnostic imaging , Male , Penicillin G/administration & dosage , Radiography
4.
J Med Microbiol ; 56(Pt 11): 1490-1494, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17965350

ABSTRACT

The therapeutic alternatives available for use against ciprofloxacin-resistant enteric fever isolates in an endemic area are limited. The antibiotics currently available are the quinolones, third-generation cephalosporins and conventional first-line drugs. In this study, the MICs of various newer drugs were determined for 31 ciprofloxacin-resistant enteric fever isolates (26 Salmonella enterica serovar Typhi and 5 S. enterica serovar Paratyphi A). MICs for ciprofloxacin, ofloxacin, gatifloxacin, levofloxacin, cefotaxime, cefixime, cefepime and azithromycin were determined using Etest strips and the agar dilution method. By Etest, all of the ciprofloxacin-resistant isolates had ciprofloxacin MICs >/=32 mug ml(-1). S. Typhi showed MIC(90) values of 0.50, 0.25 and 0.38 mug ml(-1) for cefixime, cefotaxime and cefepime, respectively. For the cephalosporins, a negligible difference in MIC(90) and MIC(50) values for S. Typhi and S. Paratyphi A was observed. A single isolate of S. Typhi showed a high azithromycin MIC of 64 mug ml(-1). The MIC(90) value for azithromycin in S. Typhi and S. Paratyphi was 24 mug ml(-1). Gatifloxacin demonstrated lower resistance (80.8 %) compared with the other quinolones (92-100 %) in S. Typhi. The rise in MIC levels of these antimicrobials is a matter for serious concern.


Subject(s)
Anti-Bacterial Agents/pharmacology , Azithromycin/pharmacology , Cephalosporins/pharmacology , Drug Resistance, Bacterial , Quinolones/pharmacology , Salmonella paratyphi A/drug effects , Salmonella typhi/drug effects , Humans , Microbial Sensitivity Tests/methods , Paratyphoid Fever/microbiology , Salmonella paratyphi A/isolation & purification , Salmonella typhi/isolation & purification , Typhoid Fever/microbiology
5.
J Ayub Med Coll Abbottabad ; 19(1): 39-41, 2007.
Article in English | MEDLINE | ID: mdl-17867478

ABSTRACT

BACKGROUND: To analyze the pathogenic organisms recovered from patients with urinary tract infection in a tertiary Indian hospital setting along with determination of the occurrence and antimicrobial sensitivity of uropathogens on a retrospective basis during a period of one year. METHODS: A total of 5073 urine samples were processed. Urine culture was done using conventional microbiological techniques. Biochemical testing was used to identify the organisms and antibiotic sensitivity was done by the Kirby Bauer method. RESULTS: A total of 2436 uropathogens were isolated. E coli were seen in 50.7% samples followed by Klebsiella sp (27.6%). Staphylococcus aureus was the commonest Gram-positive isolate (1.5%). Urinary tract infection (UTI) was seen in 70.5% females as compared to 29.5% males. A high recovery of isolates was noted from July to September. Multi drug resistance was commonest with Enterococcus (78.8%) followed by Pseudomonas (65.1%). Drugs, which retained usefulness for Gram-negative isolates, were amikacin, norfloxacin and cefotaxime. For Gram-positive isolates, vancomycin, teicoplanin, lincomycin and Norfloxacin were very effective. CONCLUSIONS: Our study highlights the changing etiology of UTI and emergence of drug resistance within the Indian subcontinent.


Subject(s)
Cross Infection/epidemiology , Drug Resistance, Bacterial , Drug Resistance, Multiple , Urinalysis , Urinary Tract Infections/urine , Enterococcus/isolation & purification , Escherichia coli/isolation & purification , Female , Humans , India/epidemiology , Klebsiella/isolation & purification , Male , Retrospective Studies , Staphylococcus aureus/isolation & purification , Urinary Tract Infections/microbiology
7.
Article in English | MEDLINE | ID: mdl-17333772

ABSTRACT

Typhoid fever remains an important public health problem in India. One thousand four hundred fifty-eight blood cultures were screened, 178 grew out Salmonella enterica serovar Typhi. On agar dilution minimum inhibitory concentration (MIC) testing, 0.6% of the isolates were resistant to ciprofloxacin, 2% to cefotaxime and 1% to cefepime. Nalidixic acid resistance was observed in 51% isolates, of which 98.9% had decreased susceptibility (MIC > or = 0.125-4 microg/ml) to ciprofloxacin. One strain of nalidixic acid sensitive S. Typhi (NASST) also had a decreased MIC (0.125 microg/ml) to ciprofloxacin. Resistance to third and fourth generation cephalosporins is emerging in India and will gain significance in the coming decade. The molecular basis of resistance to cephalosporinsand ciprofloxacin resistance in NASST strains need to be further evaluated for S. Typhi.


Subject(s)
Anti-Infective Agents/administration & dosage , Salmonella typhi/drug effects , Salmonella typhi/isolation & purification , Typhoid Fever/drug therapy , Adult , Anti-Infective Agents/therapeutic use , Colony Count, Microbial , Drug Resistance, Bacterial , Drug Resistance, Multiple, Bacterial , Female , Humans , India , Male , Typhoid Fever/diagnosis , Typhoid Fever/microbiology
8.
Indian Pediatr ; 41(10): 1040-4, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15523131

ABSTRACT

This cross sectional study was performed in a tertiary level teaching hospital to evaluate and compare the antibody levels in children below 6 years who had received oral polio vaccination through Pulse Polio Immunization (PPI) with those children who had received both routine immunization as well as PPI. Detail history of polio immunization was taken. Serum samples were then collected for antibody determination by neutralization tests with standard polio viruses using Vero cell lines. Total 400 children were studied; 14 were found unvaccinated. Out of the remaining 386 (96.5%) vaccinated children, 292 (75%) had received both routine and pulse polio immunization, 68 (17%) had only PPI while 26 (6.7%) had received only routine immunization. The seropositivity was lowest for P3 and highest for P2. Overall seroprevalence for PI, P2 and P3 in vaccinated children was 89.1%, 93% and 80.6% respectively, and did not differ significantly between the three vaccinated subgroups. However, children who were immunized by both routine and PPI had higher geometric mean titers (315.5, 484.7 and 187.4 for PI, P2 and P3 respectively) when compared with those who had received only PPI (P<0.001 for each PI, P2 and P3), as well as those who had received only routine immunization with OPV (P<0.05 for PI, p<0.001 for P2, and P<0.01 for P3). Despite the reasonable immunization coverage in study population, there were 29 (7.25%) triple negative cases. Hence other causes of low seroconversion should also be considered to achieve polio free India.


Subject(s)
Antibodies, Viral/analysis , Immunization Programs , Poliomyelitis/prevention & control , Poliovirus/immunology , Child , Child, Preschool , Cross-Sectional Studies , Humans , India , Infant , Poliomyelitis/epidemiology , Seroepidemiologic Studies
10.
Indian J Chest Dis Allied Sci ; 44(4): 271-3, 2002.
Article in English | MEDLINE | ID: mdl-12437243

ABSTRACT

A rare case of tuberculosis of the stemoclavicular joint in a 13-year-old girl is presented. The occurrence of tubercular infection in the sternoclavicular joint is extremely rare.


Subject(s)
Mycobacterium tuberculosis/isolation & purification , Sternoclavicular Joint/diagnostic imaging , Tuberculosis, Osteoarticular/diagnostic imaging , Adolescent , Antitubercular Agents/administration & dosage , Female , Follow-Up Studies , Humans , Radiography , Treatment Outcome , Tuberculosis, Osteoarticular/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...